Comparison of insulin lispro protamine suspension with NPH insulin in pregnant women with type 2 and gestational diabetes mellitus: Maternal and perinatal outcomes

International Journal of Endocrinology

Volumn 2013, Issue , 2013, Pages

  Colatrella, Antonietta ^a   Visalli, Natalia ^b   Abbruzzese, Santina ^b   Leotta, Sergio ^b   Bongiovanni, Marzia ^a   Napoli, Angela ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b SANDRO PERTINI HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN LISPRO; ISOPHANE INSULIN; SHORT ACTING INSULIN;

ADULT; ARTICLE; BIRTH WEIGHT; CONGENITAL MALFORMATION; CONTROLLED STUDY; DELIVERY; DIET RESTRICTION; DIET THERAPY; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPERTENSION; HYPOGLYCEMIA; MAJOR CLINICAL STUDY; NEWBORN; NON INSULIN DEPENDENT DIABETES MELLITUS; OBSERVATIONAL STUDY; PREGNANCY DIABETES MELLITUS; PREGNANCY OUTCOME; PREGNANT WOMAN; PRIORITY JOURNAL; RETROSPECTIVE STUDY; WEIGHT GAIN;

EID: 84880236163     PISSN: 16878337     EISSN: 16878345     Source Type: Journal    
DOI: 10.1155/2013/151975     Document Type: Article

References (41)

1. American Diabetes Association, Clinical practice recommendations: gestational diabetes. Diabetes Care 2004 27 supplement 1 88 90 10.2337/diacare.27.2007.S88
2. AACE American Association of Clinical Endocrinologists, Medical guidelines for clinical practice for the management of diabetes mellitus. Endocrine Practice 2007 13 supplement 1 55 59
3. Persson B., Swahn M. L., Hjertberg R., Hanson U., Nord E., Nordlander E., Hansson L. O., Insulin lispro therapy in pregnancies complicated by type 1 diabetes mellitus. Diabetes Research and Clinical Practice 2002 58 2 115 121 2-s2.0-0036836782 10.1016/S0168-8227(02)00141-9
4. Durnwald C. P., Landon M. B., A comparison of lispro and regular insulin for the management of type 1 and type 2 diabetes in pregnancy. Journal of Maternal-Fetal and Neonatal Medicine 2008 21 5 309 313 2-s2.0-43249084400 10.1080/14767050802022797 (Pubitemid 351652520)
5. García-Domínguez M., Herranz L., Hillman N., Martín-Vaquero P., Jáñez M., Moya-Chimenti E., Pallardo L. F., Use of insulin lispro during pregnancy in women with pregestational diabetes mellitus. Medicina Clinica 2011 137 13 581 586 2-s2.0-80455168327 10.1016/j.medcli.2010.11.021
6. Durnwald C. P., Landon M. B., Insulin analogues in the management of the pregnancy complicated by diabetes mellitus. Current Diabetes Reports 2011 11 1 28 34 2-s2.0-79551554129 10.1007/s11892-010-0160-0
7. Hod M., Damm P., Kaaja R., Visser G. H. A., Dunne F., Demidova I., Hansen A. P., Mersebach H., Insulin Aspart Pregnancy Study Group, Fetal and perinatal outcomes in type 1 diabetes pregnancy: a randomized study comparing insulin aspart with human insulin in 322 subjects. The American Journal of Obstetrics and Gynecology 2008 198 2 186.e1 186.e7 2-s2.0-38549141135 10.1016/j.ajog.2007. 08.005 (Pubitemid 351146601)
8. Mathiesen E. R., Kinsley B., Amiel S. A., Heller S., McCance D., Duran S., Bellaire S., Raben A., Maternal glycemic control and hypoglycemia in type 1 diabetic pregnancy: a randomized trial of insulin aspart versus human insulin in 322 pregnant women. Diabetes Care 2007 30 4 771 776 2-s2.0-34147093269 10.2337/dc06-1887 (Pubitemid 46556565)
9. Kitzmiller J. L., Block J. M., Brown F. M., Catalano P. M., Conway D. L., Coustan D. R., Gunderson E. P., Herman W. H., Hoffman L. D., Inturrisi M., Jovanovic L. B., Kjos S. I., Knopp R. H., Montoro M. N., Ogata E. S., Paramsothy P., Reader D. M., Rosenn B. M., Thomas A. M., Kirkman M. S., Managing preexisting diabetes for pregnancy: summary of evidence and consensus recommendations for care. Diabetes Care 2008 31 5 1060 1079 2-s2.0-44649090496 10.2337/dc08-9020
10. Negrato C. A., Rafacho A., Negrato G., Teixeira M. F., Araújo C. A. R., Vieira L., Silva C. A., Date S. K., Demarchi A. C., Gomes M. B., Glargine versus NPH insulin therapy in pregnancies complicated by diabetes: an observational cohort study. Diabetes Research and Clinical Practice 2010 89 1 46 51 2-s2.0-77953810395 10.1016/j.diabres.2010.03.015
11. Lepercq J., Jacqueminet S., Hieronimus S., Timsit J., Grimaldi A., Use of insulin glargine throughout pregnancy in 102 women with type 1 diabetes. Diabetes and Metabolism 2010 36 3 209 212 2-s2.0-77953476420 10.1016/j.diabet.2009.11.008
12. Pöyhönen-Alho M., Rönnemaa T., Saltevo J., Ekblad U., Kaaja R. J., Use of insulin glargine during pregnancy. Acta Obstetricia et Gynecologica Scandinavica 2007 86 10 1171 1174 10.1080/00016340701515282 (Pubitemid 47463728)
13. Lapolla A., Di Cianni G., Bruttomesso D., Dalfrà M. G., Fresa R., Mello G., Napoli A., Romanelli T., Sciacca L., Stefanelli G., Torlone E., Mannino D., Use of insulin detemir in pregnancy: a report on 10 Type 1 diabetic women: Letters: Original Observations. Diabetic Medicine 2009 26 11 1181 1182 2-s2.0-70350774087 10.1111/j.1464-5491.2009.02852.x
14. Mathiesen E. R., Hod M., Ivanisevic M., Garcia S. D., Brøndsted L., Jovanovic L., Damm P., McCance D. R., The Detemir in Pregnancy Study Group, Maternal efficacy and safety outcomes in a randomized, controlled trial comparing insulin detemir with NPH insulin in 310 pregnant women with type 1 diabetes. Diabetes Care 2012 35 10 2012 2017 10.2337/dc11-2264
15. Roach P., Woodworth J. R., Clinical pharmacokinetics and pharmacodynamics of insulin lispro mixtures. Clinical Pharmacokinetics 2002 41 13 1043 1057 2-s2.0-0036034873 (Pubitemid 35246781)
16. Ceriello A., Cremasco F., Romoli E., Rossi A., Gentilella R., Insulin lispro protamine suspension in the treatment of patients with type 1 and type 2 diabetes mellitus: a systematic review of published data. Expert Opinion on Pharmacotherapy 2012 13 2 255 281 2-s2.0-84855900999 10.1517/14656566.2012. 650862
17. Yehezkel E., Weinstein D., Simon M., Sarfstein R., Laron Z., Werner H., Long-acting insulin analogues elicit atypical signalling events mediated by the insulin receptor and insulin-like growth factor-I receptor. Diabetologia 2010 53 12 2667 2675 2-s2.0-78649320787 10.1007/s00125-010-1899-1
18. Carpenter M. W., Coustan D. R., Criteria for screening tests for gestational diabetes. The American Journal of Obstetrics and Gynecology 1982 144 7 768 773 2-s2.0-0020465887 (Pubitemid 13196587)
19. Metzger B. E., Coustan D. R., Summary and recommendations of the fourth international workshop-conference on gestational diabetes mellitus. Diabetes Care 1998 21 supplement 2 B161 B167 2-s2.0-0031852909 (Pubitemid 28357050)
20. American Diabetes Association, Standard of medical care in diabetes-2011. Diabetes Care 2011 34 supplement 1 11 61
21. Roccella E. J., Report of the national high blood pressure education program working group on high blood pressure in pregnancy. The American Journal of Obstetrics and Gynecology 2000 183 1 S1 S22 2-s2.0-0033891361 10.1067/mob.2000.107928 (Pubitemid 30626063)
22. Kuczmarski M. F., Kuczmarski R. J., Najjar M., Effects of age on validity of self-reported height, weight, and body mass index: findings from the third national health and nutrition examination survey, 1988-1994. Journal of the American Dietetic Association 2001 101 1 28 34 2-s2.0-0010167463 (Pubitemid 33712693)
23. Langer O., Yogev Y., Most O., Xenakis E. M. J., Gestational diabetes: the consequences of not treating. The American Journal of Obstetrics and Gynecology 2005 192 4 989 997 2-s2.0-16844382981 10.1016/j.ajog.2004.11.039 (Pubitemid 40487770)
24. Bertino E., Spada E., Occhi L., Coscia A., Giuliani F., Gagliardi L., Gilli G., Bona G., Fabris C., de Curtis M., Milani S., Neonatal anthropometric charts: the Italian neonatal study compared with other European studies. Journal of Pediatric Gastroenterology and Nutrition 2010 51 3 353 361 2-s2.0-77956451076 10.1097/MPG.0b013e3181da213e
25. Johansen K. S., Hod M., Quality development in perinatal care-the OBSQID project. International Journal of Gynecology and Obstetrics 1999 64 2 167 172 2-s2.0-0033013110 10.1016/S0020-7292(98)00210-0 (Pubitemid 29096276)
26. Siegmund T., Rad N. T., Ritterath C., Siebert G., Henrich W., Buhling K. J., Longitudinal changes in the continuous glucose profile measured by the CGMS in healthy pregnant women and determination of cut-off values. European Journal of Obstetrics Gynecology and Reproductive Biology 2008 139 1 46 52 2-s2.0-46149117283 10.1016/j.ejogrb.2007.12.006
27. de Veciana M., Major C. A., Morgan M. A., Asrat T., Toohey J. S., Lien J. M., Evans A. T., Postprandial versus preprandial blood glucose monitoring in women with gestational diabetes mellitus requiring insulin therapy. The New England Journal of Medicine 1995 333 19 1237 1241 2-s2.0-0028880530 10.1056/NEJM199511093331901
28. Colatrella A., Braucci S., Festa C., Bianchi P., Fallucca F., Mattei L., Trappolini M., Napoli A., Hypertensive disorders in normal/over-weight and obese type 2 diabetic pregnant women. Experimental and Clinical Endocrinology and Diabetes 2009 117 8 373 377 2-s2.0-70350460756 10.1055/s-0029-1220763
29. Colatrella A., Loguercio V., Mattei L., Trappolini M., Festa C., Stoppo M., Napoli A., Hypertension in diabetic pregnancy: impact and long-term outlook. Best Practice & Research. Clinical Endocrinology & Metabolism 2010 24 4 635 651 2-s2.0-79952115419
30. Blanco C. G., Ballesteros A. C., Saladich I. G., Pla R. C., Glycemic control and pregnancy outcomes in women with type 1 diabetes mellitus using lispro versus regular insulin: a systematic review and meta-analysis. Diabetes Technology and Therapeutics 2011 13 9 907 911 2-s2.0-80052075211 10.1089/dia.2011.0032
31. Edson E. J., Bracco O. L., Vambergue A., Koivisto V., Managing diabetes during pregnancy with insulin lispro: a safe alternative to human insulin. Endocrine Practice 2010 16 6 1020 1027 2-s2.0-79952391285 10.4158/EP10003.RA
32. Catalano P. M., Kirwan J. P., Haugel-De Mouzon S., King J., Gestational diabetes and insulin resistance: role in short- and long-term implications for mother and fetus. Journal of Nutrition 2003 133 5 1674S 1683S 2-s2.0-0038561127 (Pubitemid 36548675)
33. Nielsen L. R., Pedersen-Bjergaard U., Thorsteinsson B., Johansen M., Damm P., Mathiesen E. R., Hypoglycemia in pregnant women with type 1 diabetes: predictors and role of metabolic control. Diabetes Care 2008 31 1 9 14 2-s2.0-38148999538 10.2337/dc07-1066
34. Robertson H., Pearson D. W. M., Gold A. E., Severe hypoglycaemia during pregnancy in women with type 1 diabetes is common and planning pregnancy does not decrease the risk. Diabetic Medicine 2009 26 8 824 826 2-s2.0-68149096662 10.1111/j.1464-5491.2009.02769.x
35. Langer O., Conway D. L., Berkus M. D., Xenakis E. M., Gonzales O., A comparison of glyburide and insulin in women with gestational diabetes mellitus. The New England Journal of Medicine 2000 343 16 1134 1138 2-s2.0-0034687440 10.1056/NEJM200010193431601
36. Hompesch M., Ocheltree S. M., Wondmagegnehu E. T., Morrow L. A., Kollmeier A. P., Campaigne B. N., Jacober S. J., Pharmacokinetics and pharmacodynamics of insulin lispro protamine suspension compared with insulin glargine and insulin detemir in type 2 diabetes. Current Medical Research and Opinion 2009 25 11 2679 2687 2-s2.0-72549110705 10.1185/03007990903223739
37. Werner H., Chantelau E. A., Differences in bioactivity between human insulin and insulin analogues approved for therapeutic use-compilation of reports from the past 20 years. Diabetology and Metabolic Syndrome 2011 3 1, article 13 2-s2.0-79959650451 10.1186/1758-5996-3-13
38. Hiden U., Glitzner E., Hartmann M., Desoye G., Insulin and the IGF system in the human placenta of normal and diabetic pregnancies. Journal of Anatomy 2009 215 1 60 68 2-s2.0-67449155317 10.1111/j.1469-7580.2008.01035.x
39. Kurtzhals P., Schäffer L., Sørensen A., Kristensen C., Jonassen I., Schmid C., Trüb T., Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use. Diabetes 2000 49 6 999 1005 2-s2.0-0342657181 (Pubitemid 30349423)
40. Sciacca L., Cassarino M. F., Genua M., Pandini G., Le Moli R., Squatrito S., Vigneri R., Insulin analogues differently activate insulin receptor isoforms and post-receptor signalling. Diabetologia 2010 53 8 1743 1753 2-s2.0-77955515434 10.1007/s00125-010-1760-6
41. Callesen N. F., Damm J., Mathiesen J. M., Ringholm L., Damm P., Mathiesen E. R., Treatment with the long-acting insulin analogues detemir or glargine during pregnancy in women with type 1 diabetes: comparison of glycaemic control and pregnancy outcome. Journal of Maternal-Fetal and Neonatal Medicine 2013 26 6 588 592 10.3109/14767058.2012.743523